Drug recall D-0235-2022
Product
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lot# 1369117B, exp. date 11/2021
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, Parsippany, NJ
- Quantity
- 64,978 patches
- Distribution
- Nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 28, 2021
- Terminated
- February 27, 2023
Related products
- Clonidine transdermal system – drug information
- NDC 0591-3509 Clonidine transdermal system · Clonidine .2 mg/d · Actavis Pharma, Inc.
- NDC 0591-3510 Clonidine transdermal system · Clonidine .3 mg/d · Actavis Pharma, Inc.
- NDC 0591-3508 Clonidine transdermal system · Clonidine .1 mg/d · Actavis Pharma, Inc.